Measuring Sulfatase Expression and Invasion in Glioblastoma.

Methods Mol Biol

Department of Neurological Surgery, Brain Tumor Research Center, Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.

Published: January 2022

Extracellular sulfatases (SULF1 and SULF2) selectively remove 6-O-sulfate groups (6OS) from heparan sulfate proteoglycans (HSPGs) and by this process control important interactions of HSPGs with extracellular factors including morphogens, growth factors, and extracellular matrix (ECM) components. The expression of SULF1 and SULF2 is dynamically regulated during development and is altered in pathological states such as glioblastoma (GBM), a highly malignant and highly invasive brain cancer. SULF2 protein is increased in an important subset of human GBM and it helps regulate receptor tyrosine kinase (RTK) signaling and tumor growth in a murine model of the disease. By altering ligand binding to HSPGs SULF2 has the potential to modify the extracellular availability of factors important in a number of cell processes including proliferation, chemotaxis, and migration. Diffuse invasion of malignant tumor cells into surrounding healthy brain is a characteristic feature of GBM that makes therapy challenging. Here, we describe methods to assess SULF2 expression in human tumor tissue and cell lines and how to relate this to tumor cell invasion.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-1398-6_33DOI Listing

Publication Analysis

Top Keywords

sulf1 sulf2
8
sulf2
5
measuring sulfatase
4
sulfatase expression
4
expression invasion
4
invasion glioblastoma
4
extracellular
4
glioblastoma extracellular
4
extracellular sulfatases
4
sulfatases sulf1
4

Similar Publications

Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis.

Matrix Biol

December 2024

Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA. Electronic address:

Article Synopsis
  • The study investigates the role of heparan sulfate 6-O-endosulfatases (Sulf1 and Sulf2) in bone marrow hematopoiesis by using a new mouse model with specific deletion of these enzymes in myeloid cells.
  • Male LysM-Sulf knockout mice showed an age-related increase in hematopoietic stem cells and granulocyte-monocyte lineages, but a decrease in lymphoid progenitors and B cells, while red blood cell and platelet production was impaired at later stages.
  • The findings highlight age- and sex-dependent differences in hematopoiesis and 6-O-sulfation levels, suggesting that Sulfs play a crucial role in regulating blood cell development in mice.
View Article and Find Full Text PDF

Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2.

Mol Cell Proteomics

July 2024

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA; Clinical and Translational Glycoscience Research Center, Georgetown University, Washington, District of Columbia, USA; Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA.

Human extracellular 6-O-endosulfatases Sulf-1 and Sulf-2 are the only enzymes that post-synthetically alter the 6-O sulfation of heparan sulfate proteoglycans (HSPG), which regulates interactions of HSPG with many proteins. Oncogenicity of Sulf-2 in different cancers has been documented, and we have shown that Sulf-2 is associated with poor survival outcomes in head and neck squamous cell carcinoma (HNSCC). Despite its importance, limited information is available on direct protein-protein interactions of the Sulf-2 protein in the tumor microenvironment.

View Article and Find Full Text PDF

CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications.

Biochimie

August 2024

Stem Cell and Neurogenesis Group, Genomics Research Centre, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Australia; ARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology (QUT), Australia; Max Planck Queensland Centre for the Materials Science of Extracellular Matrices, Australia; Centre for Biomedical Technologies, Queensland University of Technology (QUT), 60 Musk Ave., Kelvin Grove, QLD 4059, Australia. Electronic address:

Stem cell therapies hold promise in addressing the burden of neurodegenerative diseases with human embryonic neural stem cells (hNSC-H9s) and bone marrow-derived human mesenchymal stem cells (hMSCs) as viable candidates. The induction of hMSC neurospheres (hMSC-IN) generate a more lineage-restricted common neural progenitor-like cell population, potentially tunable by heparan sulfate proteoglycans (HSPGs). We examined CpG (5 mC) site methylation patterns using Illumina Infinium 850 K EPIC arrays in hNSC-H9, hMSCs and hMSC-IN cultures with HSPG agonist heparin at early and late phases of growth.

View Article and Find Full Text PDF

Metastasis is the leading cause of cancer-associated mortality. Although advances in the targeted treatment and immunotherapy have improved the management of some cancers, the prognosis of metastatic cancers remains unsatisfied. Therefore, the specific mechanisms in tumor metastasis need further investigation.

View Article and Find Full Text PDF

Galectin-3-binding protein inhibits extracellular heparan 6--endosulfatse Sulf-2.

bioRxiv

December 2023

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.

Human extracellular 6--endosulfatases Sulf-1 and Sulf-2 are the only enzymes that post-synthetically alter the 6- sulfation of heparan sulfate proteoglycans (HSPG), which regulates interactions of HSPG with many proteins. Oncogenicity of Sulf-2 in different cancers has been documented and we have shown that Sulf-2 is associated with poor survival outcomes in head and neck squamous cell carcinoma (HNSCC). In spite of its importance, limited information is available on direct protein-protein interactions of the Sulf-2 protein in the tumor microenvironment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!